Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH; Heart Center, Nationwide Children's Hospital, Columbus, OH; National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA.
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA.
J Pediatr. 2023 Sep;260:113523. doi: 10.1016/j.jpeds.2023.113523. Epub 2023 May 25.
To evaluate the hypothesis that childhood survival for individuals with Down syndrome (DS) and congenital heart defects (CHDs) has improved in recent years, approaching the survival of those with DS without CHDs.
Individuals with DS born from 1979 to 2018 were identified through the Metropolitan Atlanta Congenital Defects Program, a population-based birth defects surveillance system administered by the Centers for Disease Control and Prevention. Survival analysis was performed to evaluate predictors of mortality for those with DS.
The cohort included 1671 individuals with DS; 764 had associated CHDs. The 5-year survival in those with DS with CHD improved steadily among individuals born in the 1980s through the 2010s (from 85% to 93%; P = .01), but remained stable (96% to 95%; P = .97) in those with DS without CHDs. The presence of a CHD was not associated with mortality through 5 years of age for those born 2010 or later (hazard ratio, 2.63; 95% CI, 0.95-8.37). In multivariable analyses, atrioventricular septal defects were associated with early (<1 year) and late (>5 year) mortality, whereas ventricular septal defects were associated with intermediate (1-5 years) mortality and atrial septal defects with late mortality, when adjusting for other risk factors.
The gap in 5-year survival between children with DS with and without CHDs has improved over the last 4 decades. Survival after 5 years remains lower for those with CHDs, although longer follow-up is needed to determine if this difference lessens for those born in the more recent years.
评估以下假设,即患有唐氏综合征(DS)和先天性心脏缺陷(CHD)的个体的儿童期生存率近年来有所提高,接近无 CHD 的 DS 患者的生存率。
通过疾病控制与预防中心管理的基于人群的出生缺陷监测系统——亚特兰大都市先天性缺陷计划,确定了 1979 年至 2018 年出生的 DS 个体。生存分析用于评估 DS 患者死亡的预测因素。
该队列包括 1671 名 DS 患者;764 例伴有 CHD。在 20 世纪 80 年代至 21 世纪 10 年代出生的患有 CHD 的 DS 患者中,5 年生存率稳步提高(从 85%提高至 93%;P=0.01),但在无 CHD 的 DS 患者中保持稳定(从 96%降至 95%;P=0.97)。对于 2010 年或以后出生的患者,CHD 的存在与 5 岁以下死亡率无关(风险比,2.63;95%CI,0.95-8.37)。在多变量分析中,房室间隔缺损与早期(<1 岁)和晚期(>5 岁)死亡相关,而室间隔缺损与中期(1-5 岁)死亡相关,房间隔缺损与晚期死亡相关,同时调整了其他危险因素。
在过去的 40 年中,患有 DS 伴或不伴 CHD 的儿童在 5 年生存率方面的差距有所缩小。尽管需要更长时间的随访来确定对于近几年出生的患者这种差异是否会减小,但患有 CHD 的患者 5 年后的生存率仍然较低。